6. Wissenschaftliches Symposium zum Welttuberkulosetag 2012
20.03.2012 09:33
VPM spricht beim 6. Wissenschaftliches Symposium zum Welttuberkulosetag 2012 in Berlin am 20./21. März 2012 zum Thema „Development of VPM1002, a novel rBCG vaccine, to replace current BCG“.
Symposium - Fighting the Scourge of TB/HIV Co-Infection, Are Vaccines and Novel Diagnostics the Solution?
03.03.2012 09:22
VPM spricht beim Symposium „FIGHTING THE SCOURGE OF TB/HIV CO-INFECTION, ARE VACCINES AND NOVEL DIAGNOSTICS THE SOLUTION?“ in München am 3. März 2012 zum Thema „Vaccine designing in TB - Challenges and hopes“.
TRANSVAC CALLS FOR NEW PARTNERS AND FREE SERVICES IN VACCINE DEVELOPMENT
01.03.2012 12:52
TRANSVAC is a collaborative infrastructure project funded under the European Commission’s (EC) 7th Framework Programme (FP7). The project is the joint effort of leading European groups in the field of vaccine development, and is coordinated by the European Vaccine Initiative (EVI). TRANSVAC was designed in order to enhance European research and training and foster the seamless implementation of a permanent research infrastructure for early vaccine development in Europe.
In order to sustain vaccine research infrastructure in Europe, the TRANSVAC consortium will consider the integration of new partners into the TRANSVAC infrastructure, mainly when they can offer services which are not covered by the current work plan.
The services provided by the potential new partners will be integrated in the advertising plan and the transnational access call in order for the potential new partners to extend their network and make their services available on a paid basis to the scientific community.
In order to sustain vaccine research infrastructure in Europe, the TRANSVAC consortium will consider the integration of new partners into the TRANSVAC infrastructure, mainly when they can offer services which are not covered by the current work plan.
The services provided by the potential new partners will be integrated in the advertising plan and the transnational access call in order for the potential new partners to extend their network and make their services available on a paid basis to the scientific community.